Thursday, July 31, 2025

Polaris of Enlightenment

After the shots – now the COVID vaccine is headed for the lungs

The criticized covid vaccinations

Published 6 May 2025
– By Editorial Staff
Initially, 350 participants are taking part in the clinical trials - but it is hoped that the vaccine will be tested on many more Canadians.
4 minute read

The COVID vaccine AeroVax is not to be injected – but inhaled according to a method that will be tested in Canada with government funding. This is despite previous vaccines being linked to millions of reported side effects and vaccine injuries, including heart muscle inflammation, blood clots, and sudden deaths.

At McMaster University in Ontario, Canada, researchers have launched a phase 2 study of a new COVID vaccine that is not administered by injection but is instead inhaled.

The vaccine, named ChAd-triCoV/Mac, will now be tested on 350 participants from across the country, with $8 million in government funding, and researchers say they hope the new vaccine will provide stronger protection against infection than previous injection-based vaccines.

While the current, needle-based COVID-19 vaccines have prevented a tremendous amount of death and hospitalization, they haven’t really changed a lot of people’s experience with getting recurrent infections, claims Fiona Smaill, professor in the Department of Pathology and Molecular Medicine and one of the study’s leaders.

We’re looking to change that by providing robust protection directly at the site of infection, she declares.

Targets three virus proteins

The new vaccine differs from previous COVID vaccines in several ways. In addition to being administered as an aerosol inhalation, it targets three different proteins in the structure of the SARS-CoV-2 virus. According to the researchers, this should improve protection against any future variants of COVID.

When a vaccine is inhaled, the body’s immune system reacts differently than when it is injected, which McMasters claims is more effective in preventing the infection itself.

Results from preclinical studies, together with unpublished data from the phase 1 study, suggest that the inhaled vaccine elicits a stronger immune response than traditional injections because it targets the airways where the virus first enters the body.

For those already vaccinated – but not recently ill

AeroVax is intended for people who have already received at least three doses of an mRNA vaccine. To participate in the study, participants must not have had COVID-19 or been vaccinated in the three months prior to registration. Participants must be between 18 and 65 years of age, free of lung disease, and able to attend all on-site testing sessions.

The study includes 350 participants from across Canada. Two-thirds will receive the vaccine and one-third a placebo. None of the participants know which group they belong to, which the researchers say is crucial for an objective evaluation.

Randomization allows for objective comparison between those who received the vaccine and those who didn’t, which can tell us a lot about the level of protection the vaccine could provide and its side effects, Smaill continues.

“Ensures the safety of participants”

The study is led by researchers at McMaster’s Michael G. DeGroote Institute for Infectious Disease Research, and all development – from laboratory design to testing – is taking place in Canada.

Every medicine or vaccine that we use and trust today has at one point gone through similar clinical trials processes, says Matthew Miller, director of the institute and a member of the research team.

This is a highly regulated process with extensive oversight that ensures the safety of participants and will generate critical data to inform the next steps in development, he adds.

If the results are promising, the researchers plan to move on to a Phase 3 study with a larger group of participants – a step toward approval and market introduction.

Previous COVID vaccines were usually administered with a syringe. Photo: Canstockphoto

Millions of side effects

In this context, it is worth mentioning that since the rollout of COVID-19 vaccines began, millions of side effects and vaccine injuries, including deaths, have been reported globally – ranging from fever and nerve damage to blood clots, heart muscle inflammation, and sudden death.

Young men have shown an increased risk of heart inflammation, which has led to certain vaccines being withdrawn or restricted in several countries, and many have come forward to testify about long-term vaccine injuries that affect their ability to work and their quality of life – but their stories have been silenced or dismissed by the healthcare system.

Critics argue that authorities and vaccine manufacturers prioritized rapid distribution over transparency and safety, and that the long-term effects are still very poorly understood.

The vaccine is also believed to have had virtually no effect on the spread of infection, and US health authorities were eventually forced to admit that vaccinated people could carry as much of the virus as unvaccinated people. In Sweden, too, healthcare providers concluded that the vaccine did not stop the spread of COVID-19.

TNT is truly independent!

We don’t have a billionaire owner, and our unique reader-funded model keeps us free from political or corporate influence. This means we can fearlessly report the facts and shine a light on the misdeeds of those in power.

Consider a donation to keep our independent journalism running…

Study: Pfizer’s covid vaccine may cause eye damage

The criticized covid vaccinations

Published 22 July 2025
– By Editorial Staff
According to the study, the covid vaccine may cause the cornea to thicken and reduce the number of important cells that keep vision clear.
2 minute read

Turkish researchers have discovered that Pfizer’s covid-19 vaccine can cause changes in the eye’s cornea that could potentially lead to vision problems. The study, which followed 64 people over three months, shows that the vaccine can make the cornea thicker and reduce the number of important cells that keep vision clear.

The researchers measured changes in the cornea’s inner layer, the endothelium, before the first vaccine dose and two months after the second dose. The results showed that both doses led to thicker corneas, fewer endothelial cells, and greater variation in cell size.

Specifically, corneal thickness increased from 528 to 542 micrometers – an increase of approximately two percent. At the same time, the number of endothelial cells decreased from 2,597 to 2,378 cells per square millimeter, a loss of about eight percent.

“The endothelium should be closely monitored in those with low endothelial cell counts or who have undergone corneal transplantation,” the researchers warn in the study published in the journal Ophthalmic Epidemiology.

Short-term impact without symptoms

In the short term, the changes suggest that Pfizer’s vaccine may temporarily weaken the endothelium, even though patients did not experience any clear vision problems during the study period. For people with healthy eyes, these small changes are unlikely to affect vision immediately.

However, if the changes persist for several years, they could lead to corneal swelling or blurred vision, particularly in people with existing eye problems or those who have undergone corneal transplantation. A thicker cornea and reduced cell density can contribute to conditions such as corneal edema or corneal decompensation, which in severe cases can cause permanent vision loss.

Need for long-term studies

The research team emphasizes the importance of long-term studies to see if the changes persist months and years after vaccination. An ophthalmologist can use special microscopy to check if someone has a low endothelial cell count.

The study adds to a growing list of concerns regarding Pfizer’s covid vaccine. In May, the US Food and Drug Administration (FDA) forced Pfizer and Moderna to expand warning labels about risks of heart damage, particularly for men between 16 and 25 years old.

Pharmaceutical giant’s top researcher on covid vaccine: “Nothing was safe and effective”

The criticized covid vaccinations

  • Joshua Rys, a leading regulatory researcher at pharmaceutical giant Johnson & Johnson (J&J), now confirms on hidden camera what mainstream media dismissed as "conspiracy theories".
  • "Do you have any idea the lack of research that was done on those products?" Rys asks rhetorically in the clip, among other things.
  • The slogans "safe and effective" that surrounded the mass vaccination campaign were, in his view, a direct lie from the authorities.
  • "This was just, let's test it on some lab route models, analyze and see if it works and stuff like that, and just roll it to the wind and see what happens", he adds.
Published 16 July 2025
– By Editorial Staff
The hidden recording confirms many concerns that have surrounded the COVID vaccines.
1 minute read

Joshua Rys leads the creation and implementation of regulatory strategies for new and existing products within Johnson & Johnson in his role.

— We run the whole soup to nuts. Not only are we working on the products, but everything that has to do with the drug. We have to make sure that you understand how to use the drug, how to be able to prescribe certain pieces of information, how to communicate that to the patient, he explains his role.

In front of independent journalist James O’Keefe’s OMG hidden cameras, he confirms that Johnson & Johnson was well aware that the preparation was not safe and effective.

— Do you have any idea the lack of research that was done on those products? You shouldn’t be surprised that this happened. It was pretty much the government kind of made a deal with pharmaceutical companies and kind of pressured the pharmaceutical companies, because we’re not going to say no to the government.

— I mean, none of that stuff was safe and effective. We didn’t do the typical test. The typical process, that’s why it takes so long to get a product on market, the typical process is all this clinical trial testing and stuff in a small population, Rys continues.

— This was just, let’s test it on some lab route models, analyze and see if it works and stuff like that, and just roll it to the wind and see what happens, he adds.

Kennedy halts US support for global vaccine alliance

The criticized covid vaccinations

Published 28 June 2025
– By Editorial Staff
According to Kennedy, Gavi has exhausted the public’s – and the US government’s – trust.
2 minute read

US Secretary of Health Robert F. Kennedy Jr. announced during a meeting in Brussels this week that the country is withdrawing its financial support for the global vaccine alliance Gavi.

The announcement comes as Gavi has launched a new funding round with the goal of raising at least $9 billion for the next five years.

Kennedy, who has long been highly skeptical of large-scale mass vaccination programs and experimental vaccines, sharply criticized Gavi and its collaboration with the World Health Organization (WHO) during the coronavirus crisis in a brief video address. He accused the alliance of systematically silencing “dissenting views” and ignoring health risks and safety issues related to the vaccines.

“In its zeal to promote universal vaccination, Gavi, the Vaccine Alliance has neglected the key issue of vaccine safety”, Kennedy later wrote in a post on X, and continued:

“When vaccine safety issues have come before GAVI, it has treated them not as a patient health problem, but as a public relations problem”.

Kennedy also questioned the safety of the combined vaccine against diphtheria, tetanus, and pertussis, claiming that research shows girls who received the vaccine are at higher risk of dying from other causes than unvaccinated children. He also expressed skepticism about WHO’s and Gavi’s recommendation to vaccinate pregnant women against COVID-19 – a recommendation he called “questionable”.

“I call on GAVI to re-earn the public trust and to justify the $8 billion dollars that America has provided in funding since 2001. Until that happens the United States won’t contribute more to GAVI. Business as usual is over”, he declared.

US promised one billion

According to Kennedy, Gavi must start “consider the best science available, even when that science contradicts established paradigms”.

In a statement on Thursday, Gavi claimed that the organization’s highest priority is children’s health and safety. They also stated that all decisions about which vaccines to procure are made according to recommendations from WHO’s expert group on vaccines.

Gavi is a global partnership between WHO, UNICEF, the Gates Foundation, the World Bank, and several governments, working to promote affordable mass vaccination programs in poor countries. The United States has long been one of the organization’s largest donors – and had, before Donald Trump’s re-election, promised support of $1 billion through 2030.

US removes COVID vaccine recommendation for children and pregnant women

The criticized covid vaccinations

Published 28 May 2025
– By Editorial Staff
Kennedy has long been highly critical of the way the Biden administration urged that even young children be injected with the experimental vaccines.
3 minute read

The US government has removed the experimental COVID-19 vaccines from the list of recommended vaccinations for healthy pregnant women and children.

We’re now one step closer to realizing President Trump’s promise to make America healthy again, declared Health Secretary Robert F. Kennedy Jr. when announcing the decision.

– I couldn’t be more pleased to announce that as of today the COVID vaccine for healthy children and healthy pregnant women has been removed from the CDC recommended immunization schedule, RFK said in a video posted on X yesterday.

According to analysts, the decision will most likely mean that significantly fewer children and pregnant women will be vaccinated with the heavily criticized vaccines in the future – partly because this is not recommended by the authorities – but also because many insurance companies will likely no longer cover the cost.

– Last year the Biden administration urged healthy children to get yet another COVID shot despite the lack of any clinical data to support the repeat booster strategy in children, Kennedy continued.

“Common sense and good science”

At the announcement, Kennedy was flanked by Food and Drug Administration (FDA) Commissioner Dr. Martin Makary and National Health Service Chief Dr. Jay Bhattacharya.

– It’s common sense and it’s good science, Bhattacharya said.

– There’s no evidence healthy kids need it today and most countries have stopped recommending it for children, Makary added.

Even the US Department of Health and Human Services press secretary, Vianca N. Rodriguez Feliciano, states that “HHS and the CDC remain committed to gold standard science and to ensuring the health and well-being of all Americans – especially our nation’s children”.

“A victory for all children and pregnant women”

Since the vaccines became available, the government has recommended them to almost all citizens including children and pregnant women.

Mary Holland, CEO of Children’s Health Defense (CHD) which early on urged the CDC not to recommend the vaccine for children and challenged the agency after the decision welcomes the announcement.

– Hallelujah! Holland said, adding: “These dangerous, poorly tested shots have caused injuries and death to far too many children. And many of the vaccines’ long-term side effects remain unknown. This is a major step in the right direction”.

– CHD urged the CDC not to add these dangerous vaccines to the childhood schedule. When we were ignored, we fought relentlessly to get them removed. This is a victory for all children and pregnant women.

In 2022, CHD sued the US federal Food and Drug Administration for granting emergency approval of COVID-19 vaccines for children and infants. The lawsuit alleged that the FDA abused its emergency use authorization power to push dangerous biological substances on minors. The organization appealed all the way to the US Supreme Court, which ultimately declined to hear the case.

“Emergency use authorized” for 5-year-olds

Even during the most panicked phases of the coronavirus crisis, experts agreed that children were at extremely low risk from COVID-19. Shortly after the vaccines were approved, side effects were reported, and peer-reviewed studies linked the vaccine to myocarditis and pericarditis, particularly in young people, in addition to several other health risks.

Despite this, public health authorities initially approved the vaccine for people aged 16 and older, and extended it to 12-year-olds in May 2021. The FDA then approved the vaccine for children aged 5 and older in October 2021, and for infants aged 6 months in June 2022.

However, the COVID-19 vaccine has never received full approval from the FDA for children under 12 it is still only authorized for use under emergency use authorization.

Nevertheless, the CDC added COVID vaccination to its routine vaccination schedule for children and adults in February 2023, after the agency’s advisory committee unanimously recommended it. The CDC has since continued to recommend annual booster doses for children.

The federal vaccination schedule also forms the basis for the vaccination recommendations given by most doctors, and also serves as formal guidance for state and local public health authorities that determine which vaccinations are required for school attendance. Children must usually have received all vaccines on the schedule to be considered “up to date”.

Our independent journalism needs your support!
We appreciate all of your donations to keep us alive and running.

Our independent journalism needs your support!
Consider a donation.

You can donate any amount of your choosing, one-time payment or even monthly.
We appreciate all of your donations to keep us alive and running.

Dont miss another article!

Sign up for our newsletter today!

Take part of uncensored news – free from industry interests and political correctness from the Polaris of Enlightenment – every week.